During the past decade, Centre Hospitalier Bretagne-Atlantique conducted 74 clinical trials. In the 10-year time frame, 74 clinical trials started and 1 clinical trials were completed, i.e. on average, 1.4% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 1 clinical trials were completed. i.e. 2.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier Bretagne-Atlantique" #1 sponsor was "Rennes University Hospital" with 15 trials, followed by "Nantes University Hospital" with 9 trials sponsored, "University Hospital, Brest" with 9 trials sponsored, "The Lymphoma Academic Research Organisation" with 6 trials sponsored and "Centre Hospitalier Departemental Vendee" with 6 trials sponsored. Other sponsors include 53 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Bretagne-Atlantique" #1 collaborator was "Biotronik SE & Co. KG" with 2 trials as a collaborator, "Daiichi Sankyo, Inc." with 2 trials as a collaborator, "Ministry of Health, France" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator and "Abbott Medical Devices" with 1 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Bretagne-Atlantique" are "Multiple Myeloma" (4 trials), "Coronary Artery Disease" (3 trials), "Covid19" (3 trials), "ARDS" (2 trials) and "Analgesia" (2 trials). Many other conditions were trialed in "Centre Hospitalier Bretagne-Atlantique" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Bretagne-Atlantique" are "Drug" (36 trials), "Other" (28 trials), "Procedure" (9 trials), "Device" (7 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Rituximab" (3 trials), "Bevacizumab" (2 trials), "Hydroxychloroquine" (2 trials) and "Lenalidomide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Bretagne-Atlantique" are 91 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier Bretagne-Atlantique". 1 are not yet recruiting, 26 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Centre Hospitalier Bretagne-Atlantique, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Bretagne-Atlantique, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 22 trials that are defined as “Not Applicable".

Centre Hospitalier Bretagne-Atlantique has several departments that took part in Clinical trials: "Ch Bretagne Atlantique; Pneumologie-Oncologie" - 2 trials, "CH Bretagne Atlantique Vannes et Auray" - 2 trials